APA

Ganzinelli M., Rulli E., Caiola E., Garassino M. C., Broggini M., Copreni E., Piva S., Longo F., Labianca R., Bareggi C., Fabbri M. A., Martelli O., Fagnani D., Locatelli M. C., Bertolini A., Valmadre G., Pavese I., Calcagno A., Sarobba M. G. & Marabese M. (20160926). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). : Scientific reports.

Chicago

Ganzinelli Monica, Rulli Eliana, Caiola Elisa, Garassino Marina Chiara, Broggini Massimo, Copreni Elena, Piva Sheila, Longo Flavia, Labianca Roberto, Bareggi Claudia, Fabbri Maria Agnese, Martelli Olga, Fagnani Daniele, Locatelli Maria Cristina, Bertolini Alessandro, Valmadre Giuseppe, Pavese Ida, Calcagno Anna, Sarobba Maria Giuseppa and Marabese Mirko. 20160926. Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). : Scientific reports.

Harvard

Ganzinelli M., Rulli E., Caiola E., Garassino M. C., Broggini M., Copreni E., Piva S., Longo F., Labianca R., Bareggi C., Fabbri M. A., Martelli O., Fagnani D., Locatelli M. C., Bertolini A., Valmadre G., Pavese I., Calcagno A., Sarobba M. G. and Marabese M. (20160926). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). : Scientific reports.

MLA

Ganzinelli Monica, Rulli Eliana, Caiola Elisa, Garassino Marina Chiara, Broggini Massimo, Copreni Elena, Piva Sheila, Longo Flavia, Labianca Roberto, Bareggi Claudia, Fabbri Maria Agnese, Martelli Olga, Fagnani Daniele, Locatelli Maria Cristina, Bertolini Alessandro, Valmadre Giuseppe, Pavese Ida, Calcagno Anna, Sarobba Maria Giuseppa and Marabese Mirko. Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). : Scientific reports. 20160926.